| A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy X Yuan, J Paez-Cortez, I Schmitt-Knosalla, F D'Addio, B Mfarrej, ... The Journal of experimental medicine 205 (13), 3133-3144, 2008 | 362 | 2008 |
| Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection L Montefusco, M Ben Nasr, F D’Addio, C Loretelli, A Rossi, I Pastore, ... Nature Metabolism 3 (6), 774-785, 2021 | 322 | 2021 |
| Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control … SB Solerte, F D’Addio, R Trevisan, E Lovati, A Rossi, I Pastore, ... Diabetes care 43 (12), 2999-3006, 2020 | 261 | 2020 |
| The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance F D’Addio, LV Riella, BG Mfarrej, L Chabtini, LT Adams, M Yeung, ... The Journal of Immunology 187 (9), 4530-4541, 2011 | 188 | 2011 |
| Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis F D’Addio, A Valderrama Vasquez, M Ben Nasr, E Franek, D Zhu, L Li, ... Diabetes 63 (9), 3041-3046, 2014 | 161 | 2014 |
| Role of podocyte B7-1 in diabetic nephropathy P Fiorina, A Vergani, R Bassi, MA Niewczas, MM Altintas, MG Pezzolesi, ... Journal of the American Society of Nephrology 25 (7), 1415-1429, 2014 | 144 | 2014 |
| Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7 A Vergani, S Tezza, F D’Addio, C Fotino, K Liu, M Niewczas, R Bassi, ... Circulation 127 (4), 463-475, 2013 | 130 | 2013 |
| PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes M Ben Nasr, S Tezza, F D’Addio, C Mameli, V Usuelli, A Maestroni, ... Science translational medicine 9 (416), eaam7543, 2017 | 127 | 2017 |
| Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site M Ben Nasr, A Vergani, J Avruch, L Liu, E Kefaloyianni, F D’Addio, ... Acta diabetologica 52, 917-927, 2015 | 111 | 2015 |
| Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection A Vergani, C Fotino, F D’Addio, S Tezza, M Podetta, F Gatti, M Chin, ... Diabetes 62 (5), 1665-1675, 2013 | 111 | 2013 |
| Interleukin-10+ Regulatory B Cells Arise Within Antigen-Experienced CD40+ B Cells to Maintain Tolerance to Islet Autoantigens S Kleffel, A Vergani, S Tezza, M Ben Nasr, MA Niewczas, S Wong, ... Diabetes 64 (1), 158-171, 2015 | 109 | 2015 |
| Anti-diabetic drugs and weight loss in patients with type 2 diabetes E Lazzaroni, MB Nasr, C Loretelli, I Pastore, L Plebani, ME Lunati, ... Pharmacological Research 171, 105782, 2021 | 97 | 2021 |
| Circulating IGF-I and IGFBP3 levels control human colonic stem cell function and are disrupted in diabetic enteropathy F D’Addio, S La Rosa, A Maestroni, P Jung, E Orsenigo, MB Nasr, ... Cell stem cell 17 (4), 486-498, 2015 | 91 | 2015 |
| Targeting the CXCR4–CXCL12 axis mobilizes autologous hematopoietic stem cells and prolongs islet allograft survival via programmed death ligand 1 P Fiorina, M Jurewicz, A Vergani, A Petrelli, M Carvello, F D’Addio, ... The Journal of Immunology 186 (1), 121-131, 2011 | 88 | 2011 |
| TIM-3: a novel regulatory molecule of alloimmune activation O Boenisch, F D’Addio, T Watanabe, W Elyaman, CN Magee, MY Yeung, ... The Journal of Immunology 185 (10), 5806-5819, 2010 | 86 | 2010 |
| A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice A Vergani, F D'Addio, M Jurewicz, A Petrelli, T Watanabe, K Liu, K Law, ... diabetes 59 (9), 2253-2264, 2010 | 84 | 2010 |
| The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists G Bendotti, L Montefusco, ME Lunati, V Usuelli, I Pastore, E Lazzaroni, ... Pharmacological Research 182, 106320, 2022 | 82 | 2022 |
| Standard heparin versus low-molecular-weight heparin: a medium-term comparison in hemodialysis S Stefoni, G Cianciolo, G Donati, L Colì, G La Manna, C Raimondi, ... Nephron 92 (3), 589-600, 2002 | 80 | 2002 |
| The rise, fall, and resurgence of immunotherapy in type 1 diabetes MB Nasr, F D’Addio, V Usuelli, S Tezza, R Abdi, P Fiorina Pharmacological research 98, 31-38, 2015 | 79 | 2015 |
| Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells X Yuan, MJ Ansari, F D'Addio, J Paez-Cortez, I Schmitt, M Donnarumma, ... Proceedings of the National Academy of Sciences 106 (26), 10734-10739, 2009 | 78 | 2009 |
Paolo FiorinaUniversità degli Studi di Milano-Boston Children's Hospital-Harvard Medical SchoolVerified email at childrens.harvard.edu
